US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report

The United States and the United Kingdom are reportedly set to reach an agreement on a zero-tariffs deal on pharmaceuticals.

According to a report by The Times, the deal will result in zero tariffs on pharmaceutical products imported in the U.S. from the U.K. It will also lead to an increase in the U.K. government’s spending on the National Health Service (NHS).

The report states that the agreement between the U.S. and the U.K. is expected to be announced in the coming days. The U.K. government is also said to have agreed to a reduction in the industry sales rebate on NHS drug prices.

AstraZeneca Plc.’s (AZN) shares were up 0.1% in Monday’s pre-market trade. Retail sentiment around the company trended in the ‘bullish’ territory at the time of writing. AstraZeneca is the U.K.’s largest pharmaceutical company.

Get updates to this story developing directly on Stocktwits.

Also See: Michael Burry Takes Aim At Musk’s Tesla Again, Says TSLA Stock Is Still ‘Ridiculously Overvalued’: Report

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on